Novosti

  • 27. 3. 2014

    Proposed dividend for Krka shareholders 30% higher than last year

    At yesterday's regular meeting, the Krka Supervisory and Management Board drew up the proposal that Krka pays its shareholders a dividend of EUR 2.10 gross per share, which is an increase of 30% on last year's dividend.

  • 27. 2. 2014

    Krka’s business performance in 2013

    The Management Board of Krka presented to the public the unaudited performance results of the Krka Group and the Krka Company for 2013.

  • 15. 11. 2013

    Krka's Annual Report awarded the best annual report of 2012

    Krka was awarded the First Prize for the best annual report among large companies in 2012 at the Best Annual Report competition organised by Finance daily newspaper for the fourteenth consecutive time. In addition, the professional committee awarded our company with a prize for the best annual report in the field of communication in 2012 among all companies.

  • 14. 11. 2013

    Presented operating results for the first nine months of 2013

    The Management Board of Krka held a press conference and presented to the public the performance results of the Krka Group and the Krka Company for the first nine months of 2013.

  • 24. 9. 2013

    Krka's international symposium on hypertension treatment in Novo mesto

    To celebrate this year’s 25th anniversary of Krka’s antihypertensive medicines acting on the renin-angiotensin-aldosterone system (RAAS), Krka organised two international symposia on hypertension treatment The Challenges, Now and Then.